Gross, A. S. et al., I&I, 61(7):2741-2747, Jul. 1993. |
Verhoef, J. et al, Eur. J. Clin Microbiol. Infect Dis., 9(4):247-250, Apr. 1990. |
Lang et al., Infect. Immun. 57:3851-3855 (1989). |
Zweerink et al., Infect. Immun. 56:1873-1879 (1988). |
Larrick et al., Human Hybridomas: Diagnostic and Therapeutic Applications A. J. Strelkaukas (ed.) (1987), pp. 65-80. |
Pier et al., Infect. Immun. 45: 309-313 (1984). |
Pier et al., J. Clin. Invest. 69: 303-308 (1982). |
Hector et al., J. Infect. Dis. 160: 483-489 (1989). |
Sawada, S. et al. "Protection Against Infection with Pseudomonas aeruginosa by Passive Transfer of Monoclonal Antibodies to Lipopolysaccharides and Outer Membrane Proteins," J. Infect. Dis. 150(4):570-576, 1984. |
Liu, P. V. et al "Survey of Heat-Stable, Major Somatic Antigens of Pseudomonas aeruginosa," Int. Journal Systematic Bacteriology 33(2): 256-264, Apr. 1983. |
Pollack, Immunoglobulins: Characteristics and Uses of Intravenous Preparations, Alving and Finlayson, eds., pp. 73-79, U.S. Department of Health and Human Services, 1979. |
Pollack and Young, J. Clin. Invest. (1979) 63:276-279. |
Cryz et al., Infect. Immun. (1983) 39:1072-1079. |
Collins and Roby, Am. J. Med. (1984) pp. 168-174. |
Zinner and McCabe, J. Infect. Dis. (1976) 133:37-45. |
Clumeck et al., Bacterial Endotoxins and Host Response, M. K. Agarwal, ed., Elsevier/North-Holland Biomedical Press, pp. 79-93, 1980. |
Teng et al., Proc. Natl. Acad. Sci. USA (1985) 82:1790-1794. |
Hornberger et al., Fed. Am. Soc. Exp. Biol., 69th Annual Meeting, 1985, Abstracts of Papers, No. 5366. |
Hancock et al., Infect. Immun. (1982) 37:166-171. |
Mackie et al., J. Immunol. (1982) 129:829-832. |
Darveau and Hancock, J. Bacteriol. (1983) 155:831-838. |
Lam et al., Infect. Immun. (1983) 42:88-98. |
Sadoff et al., Program and Abstracts of the Twenty-second Interscience Conference on Antimicrobial Agents and Chemotherapy, Oct. 1982, Abstract No. 253. |
Siadak and Lostrom, Human Hybridomas and Monoclonal Antibodies, Engleman et al., eds., Plenum Publishing Corporation, 1985, pp. 167-185. |
Sadoff et al., Antibiot. Chemother. (1985) 36:134-146. |
Sawada et al., J. Infect. Dis. (1985) 152:965-970. |
Koskimies, Scand. J. Immunol. (1980) 11:73-77. |
Steinitz et al., J. Immunol. (1984) 132:877-882. |
Yarchoan et al., J. Exper. Med. (1983) 157:1-14. |
Larrick, U.S. Statutory Invention Reg. No. H494, Jul. 5, 1988. |
Engleman, E. G. et al. Human Hybridomas and Monoclonal Antibodies, Plenum Press, New York, 1985, p. xi. |
Lang, et al., "Immunoprotective Capacities of Human and Murine Monoclonal Antibodies Recognizing Serotype-Specific and Common Determinants of Gram-Negative Bacteria", in Therapeutic Monoclonal Antibodies ed. Borrebaeck & Larrick, pp. 223-234, 1990. |